Immediate Impact

5 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Colorectal cancer
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
5 intermediate papers

Works of Aurélie Ferru being referenced

Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors
2021
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer
2013
and 2 more

Author Peers

Author Last Decade Papers Cites
Aurélie Ferru 243 82 45 104 91 30 426
Hiroki Ikezawa 283 112 33 109 71 32 482
Eisei Shin 248 117 26 115 126 30 476
Christine Gennigens 158 93 62 53 141 53 492
Luca Giuseppe Sgrò 142 75 33 88 68 31 435
Huanli Duan 147 93 24 209 97 19 385
Samuel Suzuki 222 123 28 112 205 22 439
S. C. Remick 232 74 28 38 139 25 398
Marko Buta 139 133 25 113 156 40 463
Uiju Cho 169 63 20 199 59 37 461
Zhen‐Kui Sun 107 71 38 189 146 38 491

All Works

Loading papers...

Rankless by CCL
2026